Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Erenumab

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 10Aimovig

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Aimovig

    Erenumab

    arrow
    Antibody Engineering
    Not Confirmed

    Brand Name : Aimovig

    U.S.A
    arrow
    Antibody Engineering
    Not Confirmed

    Amgen

    Erenumab

    Main Therapeutic Indication : CNS & Anesthesia

    Currency : USD

    2020 Revenue in Millions : 378

    2019 Revenue in Millions : 306

    Growth (%) : 24

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Aimovig

    Erenumab

    arrow
    Antibody Engineering
    Not Confirmed

    Brand Name : Aimovig

    U.S.A
    arrow
    Antibody Engineering
    Not Confirmed

    Amgen

    Erenumab

    Main Therapeutic Indication : Neurology

    Currency : USD

    2021 Revenue in Millions : 317

    2020 Revenue in Millions : 378

    Growth (%) : -16

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Aimovig

    Erenumab

    arrow
    Antibody Engineering
    Not Confirmed

    Brand Name : Aimovig

    Switzerland
    arrow
    Antibody Engineering
    Not Confirmed

    Novartis

    Erenumab

    Main Therapeutic Indication : CNS & Anesthesia

    Currency : USD

    2020 Revenue in Millions : 164

    2019 Revenue in Millions : 103

    Growth (%) : 59

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Aimovig

    Erenumab

    arrow
    Antibody Engineering
    Not Confirmed

    Brand Name : Aimovig

    Switzerland
    arrow
    Antibody Engineering
    Not Confirmed

    Novartis

    Erenumab

    Main Therapeutic Indication : Neurology

    Currency : USD

    2021 Revenue in Millions : 215

    2020 Revenue in Millions : 164

    Growth (%) : 31

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Aimovig

    Erenumab

    arrow
    Antibody Engineering
    Not Confirmed

    Brand Name : Aimovig

    U.S.A
    arrow
    Antibody Engineering
    Not Confirmed

    Amgen

    Erenumab

    Main Therapeutic Indication : Neurology

    Currency : USD

    2022 Revenue in Millions : 414

    2021 Revenue in Millions : 317

    Growth (%) : 31

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Aimovig

    Erenumab

    arrow
    Antibody Engineering
    Not Confirmed

    Brand Name : Aimovig

    Switzerland
    arrow
    Antibody Engineering
    Not Confirmed

    Novartis

    Erenumab

    Main Therapeutic Indication : Neurology

    Currency : USD

    2022 Revenue in Millions : 218

    2021 Revenue in Millions : 215

    Growth (%) : 1

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : Aimovig

    Erenumab

    arrow
    Antibody Engineering
    Not Confirmed

    Brand Name : Aimovig

    Switzerland
    arrow
    Antibody Engineering
    Not Confirmed

    Novartis

    Erenumab

    Main Therapeutic Indication : Neurology

    Currency : USD

    2023 Revenue in Millions : 266

    2022 Revenue in Millions : 218

    Growth (%) : 22

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Brand Name : Aimovig

    Erenumab

    arrow
    Antibody Engineering
    Not Confirmed

    Brand Name : Aimovig

    U.S.A
    arrow
    Antibody Engineering
    Not Confirmed

    Amgen

    Erenumab

    Main Therapeutic Indication : Neurological/Mental Disorders

    Currency : USD

    2018 Revenue in Millions : 119

    2017 Revenue in Millions : 0

    Growth (%) : New Launch

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Brand Name : Aimovig

    Erenumab

    arrow
    Antibody Engineering
    Not Confirmed

    Brand Name : Aimovig

    U.S.A
    arrow
    Antibody Engineering
    Not Confirmed

    Amgen

    Erenumab

    Main Therapeutic Indication : CNS & Anesthesia

    Currency : USD

    2019 Revenue in Millions : 306

    2018 Revenue in Millions : 119

    Growth (%) : 157

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Brand Name : Aimovig

    Erenumab

    arrow
    Antibody Engineering
    Not Confirmed

    Brand Name : Aimovig

    Switzerland
    arrow
    Antibody Engineering
    Not Confirmed

    Novartis

    Erenumab

    Main Therapeutic Indication : CNS & Anesthesia

    Currency : USD

    2019 Revenue in Millions : 103

    2018 Revenue in Millions : 8

    Growth (%) : 1,188

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF